Alonso, S., Guerra, A.R., Carreira, L., Ferrer, J.Á., Gutiérrez, M.L., and Fernandez-Rodriguez, C.M. 2017. Upcoming pharmacological developments in chronic hepatitis B: can we glimpse a cure on the horizon?. BMC Gastroenterol., 17, 168.

Article  Google Scholar 

Bouchard, M.J. and Schneider, R.J. 2004. The enigmatic X gene of hepatitis B virus. J. Virol., 78, 12725–12734.

CAS  Article  Google Scholar 

Cho, H.K., Kim, S.Y., Yoo, S.K., Choi, Y.H., and Cheong, J. 2014. Fatty acids increase hepatitis B virus X protein stabilization and HBxinduced inflammatory gene expression. FEBS J., 281, 2228–2239.

CAS  Article  Google Scholar 

Choi, J.W., Ahn, S.H., Park, J.Y., Chang, H.Y., Kim, J.K., Baatarkhuu, O., Kim, D.Y., Han, K.H., and Chon, C.Y. 2009. Hepatitis B e antigen-negative mutations in the precore and core promoter regions in Korean patients. J. Med. Virol., 81, 594–601.

CAS  Article  Google Scholar 

Faguer, S., Mayeur, N., Casemayou, A., Pageaud, A.L., Courtellemont, C., Cartery, C., Fournie, G.J., Schanstra, J.P., Tack, I., Bascands, J.L., et al. 2013. Hnf-1β transcription factor is an early Hif-1±-independent marker of epithelial hypoxia and controls renal repair. PLoS ONE, 8, e63585.

Article  Google Scholar 

Gustafsson, M.V., Zheng, X., Pereira, T., Gradin, K., Jin, S., Lundkvist, J., Ruas, J.L., Poellinger, L., Lendahl, U., and Bondesson, M. 2005. Hypoxia requires notch signaling to maintain the undifferentiated cell state. Dev. Cell, 9, 617–628.

CAS  Article  Google Scholar 

Hadziyannis, E. and Laras, A. 2018. Viral biomarkers in chronic HBeAg negative HBV infection. Genes, 9, 469.

Article  Google Scholar 

Jiang, Z.H., Chen, Q.Y., Harrison, T.J., Li, G.J., Wang, X.Y., Li, H., Hu, L.P., Li, K.W., Yang, Q.L., Tan, C., et al. 2016. Hepatitis B virus core promoter double mutations (A1762T, G1764A) are associated with lower levels of serum dihydrolipoyl dehydrogenase. Intervirology, 59, 1–7.

CAS  Article  Google Scholar 

Kao, J.H. and Chen, D.S. 2002. Global control of hepatitis B virus infection. Lancet Infect. Dis., 2, 395–403.

Article  Google Scholar 

Karayiannis, P. 2017. Hepatitis B virus: virology, molecular biology, life cycle and intrahepatic spread. Hepatol. Int., 11, 500–508.

CAS  Article  Google Scholar 

Kim, D.H., Kang, H.S., and Kim, K.H. 2016. Roles of hepatocyte nuclear factors in hepatitis B virus infection. World J. Gastroenterol., 22, 7017–7029.

CAS  Article  Google Scholar 

Lamontagne, R.J., Bagga, S., and Bouchard, M.J. 2016. Hepatitis B virus molecular biology and pathogenesis. Hepatoma Res., 2, 163–186.

CAS  Article  Google Scholar 

Lau, K.C.K., Joshi, S.S., Mahoney, D.J., Mason, A.L., van Marle, G., Osiowy, C., and Coffin, C.S. 2020. Differences in HBV replication, APOBEC3 family expression, and inflammatory cytokine levels between wild-type HBV and pre-core (G1896A) or basal core promoter (A1762T/G1764A) mutants. Front. Microbiol., 11, 1653.

Article  Google Scholar 

Li, J., Xu, Z., Zheng, Y., Johnson, D.L., and Ou, J.H. 2002. Regulation of hepatocyte nuclear factor 1 activity by wild-type and mutant hepatitis B virus X proteins. J. Virol., 76, 5875–5881.

CAS  Article  Google Scholar 

Madden, C.R., Finegold, M.J., and Slagle, B.L. 2001. Hepatitis B virus X protein acts as a tumor promoter in development of diethylnitrosamine induced preneoplastic lesions. J. Virol., 75, 3851–3858.

CAS  Article  Google Scholar 

MacLachlan, J.H. and Cowie, B.C. 2015. Hepatitis B virus epidemiology. Cold Spring Harb. Perspect. Med., 5, a021410.

Article  Google Scholar 

Marignol, L., Coffey, M., Lawler, M., and Hollywood, D. 2008. Hypoxia in prostate cancer: a powerful shield against tumour destruction?. Cancer Treat. Rev., 34, 313–327.

CAS  Article  Google Scholar 

Marusawa, H., Matsuzawa, S., Welsh, K., Zou, H., Armstrong, R., Tamm, I., and Reed, J.C. 2003. HBXIP functions as a cofactor of survivin in apoptosis suppression. EMBO J., 22, 2729–2740.

CAS  Article  Google Scholar 

Mirandola, S., Sebastiani, G., Rossi, C., Velo, E., Erne, E.M., Vario, A., Tempesta, D., Romualdi, C., Campagnolo, D., and Alberti, A. 2012. Genotype-specific mutations in the polymerase gene of hepatitis B virus potentially associated with resistance to oral antiviral therapy. Antiviral Res., 96, 422–429.

CAS  Article  Google Scholar 

Ohsaki, E., Suwanmanee, Y., and Ueda, D. 2021. Chronic hepatitis B treatment strategies using polymerase inhibitor-based combination therapy. Viruses, 13, 1691.

CAS  Article  Google Scholar 

Quarleri, J. 2014. Core promoter: a critical region where the hepatitis B virus makes decisions. World J. Gastroenterol., 20, 425–435.

Article  Google Scholar 

Reese, V.C., Ondracek, C.R., Rushing, C.N., Li, L., Oropeza, C.E., and McLachlan, A. 2011. Multiple nuclear receptors may regulate hepatitis B virus biosynthesis during development. Int. J. Biochem. Cell Biol., 43, 230–237.

CAS  Article  Google Scholar 

Schweitzer, A., Horn, J., Mikolajczyk, R.T., Krause, G., and Ott, J.J. 2015. Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013. Lancet, 386, 1546–1555.

Article  Google Scholar 

Tang, H. and McLachlan, A. 2001. Transcriptional regulation of hepatitis B virus by nuclear hormone receptors is a critical determinant of viral tropism. Proc. Natl. Acad. Sci. USA, 98, 1841–1846.

CAS  Article  Google Scholar 

Tong, S., Li, J., Wands, J.R., and Wen, Y.M. 2013. Hepatitis B virus genetic variants: biological properties and clinical implications. Emerg. Microbes Infect., 2, e10.

CAS  Article  Google Scholar 

Zheng, Y., Li, J., and Ou, J.H. 2004. Regulation of hepatitis B virus core promoter by transcription factors HNF1 and HNF4 and the viral X protein. J. Virol., 78, 6908–6914.

CAS  Article  Google Scholar 

Zhong, H., De Marzo, A.M., Laughner, E., Lim, M., Hilton, D.A., Zagzag, D., Buechler, P., Isaacs, W.B., Semenza, G.L., and Simons, J.W. 1999. Overexpression of hypoxia-inducible factor 1α in common human cancers and their metastases. Cancer Res., 59, 5830–5835.

CAS  PubMed  Google Scholar 

Zhou, Z., Xu, M.J., and Gao, B. 2016. Hepatocytes: a key cell type for innate immunity. Cell. Mol. Immunol., 13, 301–315.

CAS  Article  Google Scholar